Company profile
Ocean Biomedical, Inc.
PNK: OCEA · Healthcare · Biotechnology
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 22
v0.1 · 5/100 weight · pillars only
↑ market scale, workforce scale · ↓ filing timeliness, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$9.5M
Employees
7
as of 2026-08-29
Market cap
$830.4k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$9.5M-$9.5M2024
Operating income-$3.8M-$3.8M2024
Total assets$902.0k$902.0k2024
Liabilities$98.5M$98.5M2024
Equity-$97.6M-$97.6M2024
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ocean Biomedical, Inc.’s financial profile?
Ocean Biomedical, Inc. earned -$9.5M in FY2024 net income.
Peers · Healthcare
Next Generation Management Corp.——MedSmart Group Inc.——IMV Inc.——MabCure Inc.——Parallel Industries Inc.——Itoco Inc.——Neighbors
Providence →Key facts
CEOInderjote Kathuria
SectorHealthcare
IndustryBiotechnology
HeadquartersProvidence, RI
ExchangePNK: OCEA
Employees7
IPO date2021-11-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.